These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 24821609)
1. Podocalyxin-like 1 is associated with tumor aggressiveness and metastatic gene expression in human oral squamous cell carcinoma. Lin CW; Sun MS; Wu HC Int J Oncol; 2014 Aug; 45(2):710-8. PubMed ID: 24821609 [TBL] [Abstract][Full Text] [Related]
2. Podocalyxin-like 1 promotes invadopodia formation and metastasis through activation of Rac1/Cdc42/cortactin signaling in breast cancer cells. Lin CW; Sun MS; Liao MY; Chung CH; Chi YH; Chiou LT; Yu J; Lou KL; Wu HC Carcinogenesis; 2014 Nov; 35(11):2425-35. PubMed ID: 24970760 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation. Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673 [TBL] [Abstract][Full Text] [Related]
4. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma. Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593 [TBL] [Abstract][Full Text] [Related]
5. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis. Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959 [TBL] [Abstract][Full Text] [Related]
6. GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity. Lin MC; Huang MJ; Liu CH; Yang TL; Huang MC Oral Oncol; 2014 May; 50(5):478-84. PubMed ID: 24582885 [TBL] [Abstract][Full Text] [Related]
7. Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis. Zhang L; Pan HY; Zhong LP; Wei KJ; Yang X; Li J; Shen GF; Zhang Z J Oral Pathol Med; 2010 Jul; 39(6):470-6. PubMed ID: 20149058 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma. Yamano Y; Uzawa K; Shinozuka K; Fushimi K; Ishigami T; Nomura H; Ogawara K; Shiiba M; Yokoe H; Tanzawa H Int J Oncol; 2008 May; 32(5):1001-9. PubMed ID: 18425326 [TBL] [Abstract][Full Text] [Related]
9. Wnt5b promotes the cell motility essential for metastasis of oral squamous cell carcinoma through active Cdc42 and RhoA. Takeshita A; Iwai S; Morita Y; Niki-Yonekawa A; Hamada M; Yura Y Int J Oncol; 2014 Jan; 44(1):59-68. PubMed ID: 24220306 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Su L; Wang Y; Xiao M; Lin Y; Yu L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995 [TBL] [Abstract][Full Text] [Related]
11. γ-Synuclein Expression Is a Malignant Index in Oral Squamous Cell Carcinoma. Cheng JC; Chiang MT; Lee CH; Liu SY; Chiu KC; Chou YT; Huang RY; Huang SM; Shieh YS J Dent Res; 2016 Apr; 95(4):439-45. PubMed ID: 26661712 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of Src homology phosphotyrosyl phosphatase 2 (Shp2) expression in oral cancer and knockdown of Shp2 expression inhibit tumor cell viability and invasion in vitro. Xie H; Huang S; Li W; Zhao H; Zhang T; Zhang D Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Feb; 117(2):234-42. PubMed ID: 24439919 [TBL] [Abstract][Full Text] [Related]
15. Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma. Morita Y; Hata K; Nakanishi M; Omata T; Morita N; Yura Y; Nishimura R; Yoneda T Clin Exp Metastasis; 2015 Oct; 32(7):739-53. PubMed ID: 26319373 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional repression of DLEC1 associates with the depth of tumor invasion in oral squamous cell carcinoma. Chan WH; Chang KP; Yang SW; Yao TC; Ko TY; Lee YS; Tsai CL; Tsai CN Oral Oncol; 2010 Dec; 46(12):874-9. PubMed ID: 20952247 [TBL] [Abstract][Full Text] [Related]
17. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029 [TBL] [Abstract][Full Text] [Related]
18. Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7. Jung DW; Che ZM; Kim J; Kim K; Kim KY; Williams D; Kim J Int J Cancer; 2010 Jul; 127(2):332-44. PubMed ID: 19937793 [TBL] [Abstract][Full Text] [Related]
19. Bmi1 essentially mediates podocalyxin-enhanced Cisplatin chemoresistance in oral tongue squamous cell carcinoma. Zhou Y; Zhang L; Pan H; Wang B; Yan F; Fang X; Munnee K; Tang Z PLoS One; 2015; 10(4):e0123208. PubMed ID: 25915207 [TBL] [Abstract][Full Text] [Related]
20. Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma. Bhawal UK; Ozaki Y; Nishimura M; Sugiyama M; Sasahira T; Nomura Y; Sato F; Fujimoto K; Sasaki N; Ikeda MA; Tsuji K; Kuniyasu H; Kato Y Oncology; 2005; 69(3):246-55. PubMed ID: 16127291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]